1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35278900 | Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway. | 2022 Feb 27 | 1 |